Center Book Partners LP Mirum Pharmaceuticals, Inc. Call Options Transaction History
Center Book Partners LP
- $1.38 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MIRM
# of Institutions
183Shares Held
54.3MCall Options Held
85KPut Options Held
59.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$222 Million8.57% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$149 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$113 Million1.34% of portfolio
-
State Street Corp Boston, MA2.82MShares$96.5 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$94.6 Million0.04% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.26B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...